Abstract:Xueming Yang, 1– 4, &ast Teng Xu, 1, 2, 4, &ast Xiaomeng Song, 1, 2, 4 Yunong Wu 1, 2, 4 1 Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China; 2 Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China; 3 Department of Stomatology, the Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China; 4 Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yunong Wu, Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Stomatology, Nanjing Medical University, No. 1, Shanghai Road, Nanjing, Jiangsu, 210029, People's Republic of China, Tel +86-25-69593100, Email Background: Neuropilin-1 (NRP1) is a significant molecular structure that participates in many diseases progress including malignant tumors. However, its role in head and neck squamous cell carcinoma (HNSCC) remains to be uncovered. In this study, we determined the function of NRP1 as a crucial biomarker in proliferation, metastasis and immunosuppression in HNSCC. Methods: We collected samples of normal tissues (n = 18) and HNSCC tissues (n = 202) for immunohistochemical staining of NRP1 and evaluated its correlation to clinical prognostic characteristics. Furthermore, we enrolled 37 HNSCC patients received immune checkpoint blockade (ICB) treatment with defined therapeutic effects records. The biological process, signal pathways, and immune infiltration relevance to NRP1 were analyzed utilized transcriptome data from The Cancer Genome Atlas (TCGA). Results: The NRP1 protein expression was significantly upregulated in HNSCC tissue and was associated with T stage, N stage, histological differentiation, recurrence and NRP1 expression. The high expression of NRP1 indicated poor survival rate and was found to be an independent prognosis factor. Enrichment analysis showed that NRP1 was associated with cell adhesion, extracellular matrix organization, homophilic cell adhesion via plasma membrane in biological process and neuroactive ligand–receptor interaction, protein digestion and absorption, calcium signal pathways. Moreover, NRP1 mRNA level was found positively correlated to cancer associated fibroblast cells, Treg cells and macrophage/monocyte cells. Conclusion: NRP1 might be likely to develop into a potential immunoregulation target as well as a predictive biomarker in HNSCC immune treatment. Keywords: NRP1, head and neck squamous cell carcinoma, immunosuppression, prognosis, bioinformatics Head and neck cancer is identified as the 6th most common cancer worldwide and squamous cell carcinoma is the most common subtype accounting for approximately 95% in head and neck malignant lesions. 1 Though radical excision combined with postoperative adjuvant radiotherapy, the overall survival does not improve obviously over the past three decades. Apart from the traditional risk factors including smoking, alcohol 2,3 and human papillomavirus (HPV) infection, 4–6 immunosuppressive status and immune escape have been the hot research topics in recent years. 7,8 Although some drugs of immune checkpoint inhibitors have been approved by Food and Drug Administration (FDA), the responsivity is still at a low level. Therefore, the mechanisms of immunosuppressive status and immune escape are urgently to be elucidated. Neuropilin-1 (NRP1) is recognized as an important membrane-spanning protein that participates in many different signaling pathways. 9,10 It has been reported to involve in metastasis and radiation resistance in tumor progression. 11–13 Generally, NRP1 serves as the ligands or co-receptors including semaphorin family members and vascular endothelial growth factor (VEGF). 10,14 In breast cancer, up regulation of the VEGF/NRP1 is associated with the enhancement of epithelial-mesenchymal transition (EMT) process and the NF-κB, β-catenin signaling. 15,16 Recently, NRP1 was found to be an entrance of SARS-CoV-2 virus except ACE2 and simultaneously blocked NRP1/ACE2 and viral spike protein integration might be a valuable treatment option. 17 Tumor-infiltrating immune cell is an important component of tumor associated microenvironment (TAM). In normal tissue, the relative balance is maintained to keep the homeostasis of microenvironment, -Abstract Truncated-

Role of NRP1 in Bladder Cancer Pathogenesis and Progression

NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation

Mechanistic study of NUPR1 in bladder cancer development through transcriptional regulation of CCR2

Bioinformatics analysis and clinical significance of NRP-1 in triple-negative breast cancer

Overexpression of NRP1 is Associated with Poor Prognosis via Accelerating Immunosuppression in Head and Neck Squamous Cell Carcinoma

Immune Inactivation by Neuropilin-1 Predicts Clinical Outcome and Therapeutic Benefit in Muscle-Invasive Bladder Cancer

LncRNA NRON Promotes the Proliferation, Metastasis and EMT Process in Bladder Cancer

Neuropilin‐1 is Up‐regulated by Cancer‐associated Fibroblast‐secreted IL‐8 and Associated with Cell Proliferation of Gallbladder Cancer

LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer

NRP-1 Silencing Suppresses Bladder Cancer Cell Line Proliferation Both in Vitro and in Vivo

Targeting neuropilin-1 interactions is a promising anti-tumor strategy

The regulation of Neuropilin 1 expression by miR-338-3p promotes non-small cell lung cancer via changes in EGFR signaling.

Role of NRP-1 in VEGF-VEGFR2-Independent Tumorigenesis

Neuropilin 1 Expression Correlates with the Radio-resistance of Human Non-Small-cell Lung Cancer Cells

RPN2 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis Via the PI3K-Akt Pathway

NRP1 Promotes Cell Migration and Invasion and Serves As a Therapeutic Target in Nasopharyngeal Carcinoma

Neuropilin 1 Modulates TGF‑β1‑induced Epithelial‑mesenchymal Transition in Non‑small Cell Lung Cancer

KPNA2 interaction with CBX8 contributes to the development and progression of bladder cancer by mediating the PRDM1/c-FOS pathway

The miR-124-3p/Neuropilin-1 Axis Contributes to the Proliferation and Metastasis of Triple-Negative Breast Cancer Cells and Co-Activates the TGF-β Pathway

VEGF/NRP-1 Axis Promotes Progression of Breast Cancer Via Enhancement of Epithelial-Mesenchymal Transition and Activation of NF-κB and Β-Catenin

NRP1 is a Prognostic Factor and Promotes the Growth and Migration of Cells in Intrahepatic Cholangiocarcinoma.